Header cover image

U.S. Life Sciences Industry Analysis

UpdatedNov 28, 2022
DataAggregated Company Financials
Companies75
  • 7D2.4%
  • 3M-0.4%
  • 1Y-28.3%
  • YTD-24.2%

The Life Sciences industry is up 2.4% in the last week, with Thermo Fisher Scientific up 3.0%. In the past year, the industry is down 28%. Earnings are forecast to grow by 14% annually.

Industry Valuation and Performance

Has the U.S. Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 28 Nov 2022US$767.3bUS$155.1bUS$8.8b28.6x87.3x4.9x
Wed, 26 Oct 2022US$722.8bUS$152.9bUS$17.4b27x41.4x4.7x
Fri, 23 Sep 2022US$717.1bUS$152.2bUS$17.3b25.8x41.4x4.7x
Sun, 21 Aug 2022US$817.8bUS$152.3bUS$17.3b31.1x47.2x5.4x
Tue, 19 Jul 2022US$747.8bUS$148.1bUS$20.1b30.8x37.2x5.1x
Thu, 16 Jun 2022US$693.9bUS$148.1bUS$20.1b28.3x34.5x4.7x
Sat, 14 May 2022US$726.2bUS$148.0bUS$20.0b30.4x36.2x4.9x
Mon, 11 Apr 2022US$896.9bUS$146.5bUS$25.3b37.3x35.4x6.1x
Wed, 09 Mar 2022US$805.2bUS$146.2bUS$25.3b33.7x31.9x5.5x
Fri, 04 Feb 2022US$864.9bUS$139.7bUS$26.9b39.1x32.2x6.2x
Sun, 02 Jan 2022US$999.2bUS$138.0bUS$27.3b44.9x36.6x7.2x
Tue, 30 Nov 2021US$970.9bUS$138.0bUS$27.3b46.5x35.6x7x
Thu, 28 Oct 2021US$742.3bUS$106.6bUS$18.7b47.5x39.7x7x
Sat, 25 Sep 2021US$766.7bUS$105.9bUS$18.6b53.1x41.1x7.2x
Mon, 23 Aug 2021US$721.6bUS$105.8bUS$18.7b50.9x38.7x6.8x
Sat, 10 Jul 2021US$656.3bUS$101.0bUS$17.6b39.3x37.2x6.5x
Fri, 02 Apr 2021US$569.5bUS$92.3bUS$15.4b38.8x37x6.2x
Mon, 04 Jan 2021US$553.9bUS$89.0bUS$14.2b39x39x6.2x
Thu, 08 Oct 2020US$450.0bUS$79.8bUS$11.8b38.6x38.2x5.6x
Wed, 01 Jul 2020US$388.7bUS$77.1bUS$8.8b38.4x44x5x
Sat, 04 Apr 2020US$302.9bUS$77.3bUS$8.5b30.2x35.5x3.9x
Tue, 07 Jan 2020US$360.7bUS$76.7bUS$8.9b35.2x40.4x4.7x
Price to Earnings Ratio

49.4x


Total Market Cap: US$346.8bTotal Earnings: US$7.0bTotal Revenue: US$75.6bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Life Sciences Industry Price to Earnings3Y Average 40.4x202020212022
Current Industry PE
  • Investors are optimistic on the American Life Sciences industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 87.3x which is higher than its 3-year average PE of 40.4x.
  • The 3-year average PS ratio of 5.6x is higher than the industry's current PS ratio of 4.9x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences industry have grown 7.8% per year over the last three years.
  • Revenues for these companies have grown 27% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the U.S. Healthcare industry?

US Market1.26%
Healthcare1.63%
Life Sciences2.40%
Clinical Research and Equipment2.40%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
TMO Thermo Fisher ScientificUS$551.253.0%
+US$6.3b
-13.7%PE30.9x
DHR DanaherUS$267.042.5%
+US$4.7b
-17.6%PE29.3x
A Agilent TechnologiesUS$156.967.4%
+US$3.0b
3.2%PE36.9x
IQV IQVIA HoldingsUS$219.982.9%
+US$1.2b
-16.1%PE34.6x
MTD Mettler-Toledo InternationalUS$1.45k3.5%
+US$1.1b
-3.1%PE38.6x
Simply Wall St
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

CTKB

US$14.30

Cytek Biosciences

7D

-3.1%

1Y

-24.8%

MTD

US$1,449.69

Mettler-Toledo International

7D

3.5%

1Y

-3.1%

ABCL

US$13.52

AbCellera Biologics

7D

-4.5%

1Y

-3.4%

A

US$156.96

Agilent Technologies

7D

7.4%

1Y

3.2%

BNGO

US$2.22

Bionano Genomics

7D

-10.1%

1Y

-44.5%

TMO

US$551.25

Thermo Fisher Scientific

7D

3.0%

1Y

-13.7%

MEDP

US$217.81

Medpace Holdings

7D

-1.3%

1Y

3.7%

RGEN

US$171.58

Repligen

7D

-2.5%

1Y

-40.0%

ILMN

US$218.99

Illumina

7D

-0.7%

1Y

-40.8%

OLK

US$22.03

Olink Holding

7D

-4.2%

1Y

-1.4%

PACB

US$10.11

Pacific Biosciences of California

7D

-4.7%

1Y

-56.6%